Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
The fund delivered 3.0% but lagged its benchmark during a highly speculative, AI-driven quarter. It maintains a cautious posture due to high valuations, selectively buying high-quality compounders like Adidas.
Full Quick Take
The fund delivered 3.0% but lagged its benchmark during a highly speculative, AI-driven quarter. It maintains a cautious posture due to high valuations, selectively buying high-quality compounders like Adidas.
Castlebay attributes its recent underperformance to avoiding a handful of expensive, low-quality cyclicals that they expect will succumb to 'financial gravity.' The fund remains committed to high-ROE, strongly-branded compounders, exiting AutoZone on valuation and adding to Novo Nordisk, Domino's, Diageo, and LSE Group.
Full Quick Take
Castlebay attributes its recent underperformance to avoiding a handful of expensive, low-quality cyclicals that they expect will succumb to 'financial gravity.' The fund remains committed to high-ROE, strongly-branded compounders, exiting AutoZone on valuation and adding to Novo Nordisk, Domino's, Diageo, and LSE Group.
The AMG Yacktman Fund returned 5.77% in Q2 2025, outperforming the Russell 1000 Value Index. The managers remain cautious on lofty market valuations but confident in their disciplined, long-term approach.
Full Quick Take
The AMG Yacktman Fund returned 5.77% in Q2 2025, outperforming the Russell 1000 Value Index. The managers remain cautious on lofty market valuations but confident in their disciplined, long-term approach.
Tidefall Capital outlines a constructive case for Crocs (CROX), stating that at 8.4x 2025 earnings estimates, the market is pricing in too much pessimism around the HeyDude acquisition and fad risk, while ignoring core profitability and stellar executive hires.
Full Quick Take
Tidefall Capital outlines a constructive case for Crocs (CROX), stating that at 8.4x 2025 earnings estimates, the market is pricing in too much pessimism around the HeyDude acquisition and fad risk, while ignoring core profitability and stellar executive hires.